[1] |
CHEN Keyu, HUANG Yuan, WANG Xiaojia, ZHENG Yabing.
Clinical application and research progress of antibody drugs conjugation in breast cancer
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2023, 28(8): 898-909.
|
[2] |
ZHANG Zhiying, JIN Xiuhong, ZHANG Xiaoning, ZHANG Xiangfeng, LUO Qinglin, ZHANG Songlin.
Clinical study of TBX21 and ADCY9 polymorphisms in the develop- ment of childhood asthma
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2023, 28(4): 407-412.
|
[3] |
GAO Lili, WANG Yuzhu, WANG Yan, LI Jian, WANG Jun.
General considerations for clinical pharmacology of antitumor antibody-conjugated drugs: Implications from FDA review cases
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2023, 28(1): 75-85.
|
[4] |
LI Shanshan, GU Jingwen, ZHANG Jing, YANG Haijing, LIU Wei, YU Yiqi, ZHANG Wenhong.
Design and evaluation of clinical trials of COVID-19 vaccine and monoclonal neutralizing antibody
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2022, 27(2): 190-197.
|
[5] |
ZHENG Fengjia, JIA Zhijun, XIE Xinyao, HAN Min, DONG Lihou.
A surey of bioanalysis methods for antibody drugs
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2020, 25(2): 227-232.
|
[6] |
YANG Xinyi, ZHANG Jing, LI Nanyang, YANG Haijing, MAO Xiaomeng.
New progress in drug prevention and treatment of migraine
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2020, 25(12): 1429-1435.
|
[7] |
YU Shuyuan, ZHENG Lin, HAN Fei.
Pathogenesis and treatment progress of antineutrophil cytoplasmic antibody-associated vasculitis
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2018, 23(2): 235-240.
|
[8] |
CHEN Yan, YE Bin, MOU Wen-yuan, YU Cheng-bo, LIN Bu, YIN Xiang-peng, XU Hong-miao.
Effect of anti-tumor necrosis factor antibody on TRAIL and TNF-α expression induced by lipopolysaccharide in human periodontal ligament fibroblasts
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2015, 20(5): 493-498.
|
[9] |
WANG Yan, LV Li.
Applications of Eculizumab, a humanized anti-complement factor C5 monoclonal antibody
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2015, 20(4): 455-459.
|
[10] |
SHANG Li-na, HONG Ming-yue.
Recent progresses on antibody-targeted conjugates of antitumor antibiotics
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2014, 19(9): 1075-1080.
|
[11] |
CAO Ying-ya, LU Wei-hua, JIANG Xiao-gan, LU Mei-jing, WU Jing-yi, QIN Xue-mei, YAO Wei-dong.
Difference in time-course of relaxant effect of rocuronium in acetylcholine receptors antibody seropositive and seronegative patients with myasthenia gravis
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2014, 19(10): 1153-1157.
|
[12] |
ZHANG Meng-ying, LI Zhi, LV Kun, ZHONG Min, SUO Qi-feng, ZHONG Zheng-ling.
The level of anti-endothelial cell antibody and anti-β2GP-Ⅰantibody in serum with systemic lupus erythematosus and the variation of human umbilical veins endothelial cell cultured in serum with SLE
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2013, 18(2): 142-146.
|
[13] |
SONG Hai-jing, YANG Wei-zhi, ZHANG Zhuo-mei, OU Lun, Chen Fang, Wang Qing-qing, DONG Li-hou, LIU Xiu-wen.
Clinical Phase I Pharmacokinetics of rhproUK
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2012, 17(6): 672-676.
|
[14] |
CAI Yong-ming, CHEN Zheng-min, SUN Chao-yuan, LIU Chang-xiao.
Bioanalytical method and pharmacokinetics of Bacillus subtilis fibrinolytic enzyme in rhesus monkeys
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2010, 15(1): 27-31.
|
[15] |
SHEN Su-jian, WU Jin-ming, JIN Si-si, HUANG Zhi-ming, WU Jian-sheng.
Antitumoral effect of the immunoconjugate composed of ricin A-chain and EGFR mab
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2009, 14(11): 1234-1238.
|